Sign inJoin waitlistJoin the waitlist

Michael York

Director, Scleroderma Program · Boston University Medical Center

Credentials: · · · ·

History

Rheumatology Multidisciplinary Lupus Program · Boston University Medical Center
Present
Boston University Medical Center
Present
Boston University Medical Center
Present

Rheumatology
Boston University Medical Center
2002–2004
Internal Medicine
Boston University Medical Center
1999–2002
University of New Hampshire, BS
University of Massachusetts T.H. Chan School of Medicine
1995–1999
University of New Hampshire
1991–1995

Research

Proteome-wide analysis and CXCL4 as a biomarker in systemic sclerosis
New England Journal of Medicine · 2014 · 375 citations
Fresolimumab treatment decreases biomarkers and improves clinical symptoms in systemic sclerosis patients
Journal of Clinical Investigation · 2015 · 299 citations
A macrophage marker, Siglec-1, is increased on circulating monocytes in patients with systemic sclerosis and induced by type I interferons and toll-like receptor agonists
Arthritis & Rheumatism · 2007 · First of 6 authors · 266 citations

Robert Lafyatis
11 papers
Amar Dhand
4 papers
BO
Bisola Ojikutu
4 papers
CF
Candace Feldman
4 papers
Mia Chandler
4 papers · 3 as a fellow
Monica Crespo-Bosque
4 papers
Robert Simms
4 papers
Rosalind Ramsey-Goldman
4 papers
Eugene Kissin
3 papers
Muriel Jean-Jacques
3 papers
Cristina Padilla
2 papers
David Hunter
2 papers